PeptideTrust
A vetted clinic directory and live FDA-status tracker that tells wellness-curious adults whether each peptide they keep hearing about is legal to obtain, where to find a licensed prescriber, and what the safety evidence actually says.
wellness-curious adults 30-55 researching peptide therapy for recovery, longevity, or inflammation
- Vetted clinic directory with license verification, pricing transparency, and patient-reported outcomes
- Live FDA-status tracker per peptide (BPC-157, GHK-Cu, thymalin, etc.) updated after each PCAC vote
- Plain-English explainer of how each peptide works and what the actual safety evidence shows
- Side-by-side comparison of in-clinic vs compounding-pharmacy sourcing with risk notes
FDA's PCAC met this week on whether to add 7 peptides to the 503A Bulks List with RFK Jr. pushing to ease restrictions, and 2000+ US searches for 'fda peptides' show a consumer audience desperate for clarity on changing rules.
Multiple 2026 peptide cost/pricing guides and active Google search interest; consumers already spend $250–600/month on therapy, indicating real willingness to research, though the cited '2000+ searches' number is unverified.How Much Does Peptide Therapy Cost? 2026 Pricing Guide ↗The FDA and Peptides: Current Regulatory Landscape in 2025 ↗
Highly crowded space: PeptideClarity already ships an FDA regulatory tracker + directory + subscription, PeptideBase lists 2,745+ verified providers, and PeptideSamples, PeakedLabs, FormBlends, GetPeptideWise, SeekPeptides and Nuletic all occupy adjacent directory/comparison niches — this idea is essentially a clone of PeptideClarity.Peptide FDA Regulatory Tracker: PCAC, 503A/503B Status — PeptideClarity ↗Peptide Therapy Directory | PeptideBase ↗Peptide Samples | Your directory to peptide telehealth ↗
Consumers paying $250–600/month for therapy can absorb a low-ticketed directory/tracker subscription (PeptideClarity already runs one), and clinic affiliate fees are realistic; however, free directories (PeptideBase, PeptideSamples) commoditize the category.How Much Does Peptide Therapy Cost? 2026 Pricing Guide ↗Peptide FDA Regulatory Tracker — PeptideClarity ↗
Regulatory environment is highly volatile — PCAC meets July 23–24, 2026 on seven peptides, with FDA tightening on GLP-1s while loosening on Category 2 peptides; this creates short-term demand for a tracker but the market could collapse or normalize depending on outcomes, making longevity uncertain.FDA Peptide Advisory Committee: What It Means | Novusyn ↗Section 503A Bulks List: PCAC, Peptide Compounding, July 23-24 Vote ↗
A directory is straightforward to build but vetting 2,700+ clinics and maintaining a live FDA-status tracker across 15+ compounds with shifting PCAC outcomes is significant ongoing editorial/legal work, not trivial.Peptide Therapy Directory | PeptideBase ↗Peptide FDA Regulatory Tracker — PeptideClarity ↗